SUPN insider buying and SEC filings, explained
Supernus Pharmaceuticals, Inc. · CIK 1356576
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- SUPERNUS PHARMACEUTICALS INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$1.8M
Planned sales (10b5-1)
$8.4M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 16–18, 2026 | Planned (10b5-1) | Padmanabh P. Bhatt (Sr. VP of IP, CSO) sold 107,250 shares between Mar 16 and Mar 18 at about $50.24 ($5.4M), marked as a 10b5-1 plan trade. Holdings down 86% to 17,044 shares. | SEC filing Filed Mar 18, 2026 |
| Mar 13, 2026 | Planned (10b5-1) | Jack A. Khattar (CEO and Director) sold 35,000 shares indirectly (by trust) at about $50.37 ($1.8M), marked as a 10b5-1 plan trade. Holdings by trust down 4% to 958,100 shares. | SEC filing Filed Mar 16, 2026 |
| Mar 12, 2026 | Sale | Frederick M. Hudson (Director) sold 5,369 shares at about $50.61 ($272K). Holdings down 8% to 60,413 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Mar 9–10, 2026 | Sale | William Todd Horich (SVP, Commercial Operations) sold 8,877 shares between Mar 9 and Mar 10 at about $54.50 ($484K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 10, 2026 |
| Mar 9, 2026 | Sale | Frank Mottola (SVP, Chief Tech. Ops. Officer) sold 1,623 shares at $53.65 ($87K). Holdings down 8% to 18,440 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 10, 2026 |
| Mar 5–6, 2026 | Sale | Georges Gemayel (Director) sold 18,787 shares between Mar 5 and Mar 6 at about $53.38 ($1.0M). Holdings down 41% to 27,277 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Feb 19, 2026 | Planned (10b5-1) | Bethany Sensenig (Director) sold 4,475 shares at about $51.01 ($228K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Feb 23, 2026 |
| Dec 19, 2025 | Planned (10b5-1) | Frank Mottola (SVP, Chief Tech. Ops. Officer) sold 20,000 shares at about $50.41 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 56% to 15,496 shares. | SEC filing Filed Dec 22, 2025 |
55 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 10:50 AM ET 8-K | Delisting or listing-rule notice (Item 3.01) | SEC filing | |
| Nov 2, 2026, 9:28 AM ET 8-K | Material agreement (Item 1.01) Acquisition or disposal completed (Item 2.01) New debt or obligation (Item 2.03) Change to shareholder rights (Item 3.03) Change in control (Item 5.01) Bylaws or fiscal-year change (Item 5.03) Reg FD disclosure (Item 7.01) | SEC filing | |
| Oct 29, 2026, 4:08 PM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SUPN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.